SentiMag® Intraoperative Comparison in Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Breast Cancer
Interventions
DEVICE

SiennaXP

Sub-cutaneous injection of SiennaXP magnetic marker, followed by lymph node localization using the SentiMag handheld magnetic probe

DRUG

Technetium Tc99m Sulfur Colloid

Injection of a single dose of radioisotope (Technetium Tc99m Sulfur Colloid)

DRUG

Isosulfan blue dye

Injection of a single dose of isosulfan blue dye

Trial Locations (6)

18104

Coordinated Health Breast Care Specialists, Allentown

75230

Dallas Surgical Group, Dallas

94115

UCSF Carol Franc Buck Breast Care Center, San Francisco

95817

University of California Davis Comprehensive Cancer Center, Sacramento

92093-0698

University of California San Diego Moores Cancer Center, La Jolla

77030-4008

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Regulatory and Clinical Research Institute Inc

OTHER

lead

Endomagnetics Inc

INDUSTRY

NCT02336737 - SentiMag® Intraoperative Comparison in Breast Cancer | Biotech Hunter | Biotech Hunter